GlaxoSmithKline welcomes NICE guidance issued on Wednesday 26th March, which recommends combination treatments such as Seretide® (salmeterol/fluticasone propionate) as an option for adults, needing both an inhaled corticosteroid (ICS) and a long-acting beta2 agonist (LABA) to control their asthma.
(more...)